GlassScriptPhysician profile
Faran Bokhari
NPI 1508987868
$9,082.56
in general payments reported to CMS, 2019-2025
12 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,188 · 2020: $123 · 2022: $270 · 2023: $1,416 · 2024: $307 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,288 · Food and Beverage: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,288.15 |
| Food and Beverage | $1,214.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $6,101.06 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,416.03 | 2023 | Advantagerib |
| Polynovo North America LLC | $551.63 | 2022-2025 | Novosorb Btm |
| Kerecis Limited | $203.43 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $138.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $127.00 | 2024 | Andexxa |
| Intuitive Surgical, INC. | $123.80 | 2025 | |
| Procept Biorobotics Corporation | $119.46 | 2025 | |
| Medical Device Business Services, INC. | $116.78 | 2025 | Surgicel Nu-Knit |
| Merck Sharp & Dohme LLC | $101.26 | 2019 | |
| Acell, INC. | $55.77 | 2019 | |
| Z-Medica, LLC | $28.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faran Bokhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.